3/24
02:03 am
dibs
1stdibs.Com, Inc. (NASDAQ: DIBS) had its "sell (d-)" rating re-affirmed by analysts at Weiss Ratings.
Low
Report
1stdibs.Com, Inc. (NASDAQ: DIBS) had its "sell (d-)" rating re-affirmed by analysts at Weiss Ratings.
3/8
01:33 am
dibs
1stdibs.Com, Inc. (NASDAQ: DIBS) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.
Medium
Report
1stdibs.Com, Inc. (NASDAQ: DIBS) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.
2/28
07:16 am
dibs
1stDibs Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
Low
Report
1stDibs Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
2/28
07:00 am
dibs
1stDibs Reports Fourth Quarter and Full Year 2024 Financial Results
Low
Report
1stDibs Reports Fourth Quarter and Full Year 2024 Financial Results
2/20
02:31 am
dibs
1stdibs.Com, Inc. (NASDAQ: DIBS) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.
Low
Report
1stdibs.Com, Inc. (NASDAQ: DIBS) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.
2/11
04:10 pm
dibs
1stDibs to Announce Fourth Quarter and Year End 2024 Financial Results on February 28, 2025
Low
Report
1stDibs to Announce Fourth Quarter and Year End 2024 Financial Results on February 28, 2025
2/4
02:07 am
dibs
1stdibs.Com, Inc. (NASDAQ: DIBS) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.
Medium
Report
1stdibs.Com, Inc. (NASDAQ: DIBS) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.
1/22
09:00 am
dibs
1stDibs Reveals Luxury E-commerce Report for 2024
Neutral
Report
1stDibs Reveals Luxury E-commerce Report for 2024
1/19
06:36 pm
dibs
1stdibs.Com, Inc. (NASDAQ: DIBS) had its "sell (d-)" rating re-affirmed by analysts at Weiss Ratings.
Low
Report
1stdibs.Com, Inc. (NASDAQ: DIBS) had its "sell (d-)" rating re-affirmed by analysts at Weiss Ratings.
1/19
06:34 pm
dibs
1stdibs.Com, Inc. (NASDAQ: DIBS) had its "sell (d-)" rating re-affirmed by analysts at Weiss Ratings.
Low
Report
1stdibs.Com, Inc. (NASDAQ: DIBS) had its "sell (d-)" rating re-affirmed by analysts at Weiss Ratings.